半球间转移时间测试的检验:一种可纳入脑转移患者治疗策略的新型计算机化认知测试?一项先导研究
该先导研究纳入29例接受立体定向放疗(33 Gy/3次)的脑转移患者,在放疗前及放疗后1个月、6个月、1年重复进行半球间转移时间测试(IHTTT)、简易精神状态检查(MMSE)、额叶评估成套测验(FAB)及QLQ-C30生活质量问卷。IHTTT指标随时间显著变化,MMSE亦显著变化,而FAB及生活质量评分无显著变化;IHTI与无进展生存期强相关。
要点
- IHTTT可检出脑转移患者SRT后认知功能随时间的变化。
- IHTT与IHTI在基线至1年随访期间均显著变化。
- MMSE显著变化,但FAB与生活质量评分未显著变化。
核心结论
- 结果提示IHTTT能够检出认知功能随时间的变化。
- IHTTT可能是一种有价值的敏感认知测试,可纳入接受SRT的脑转移患者的评估中。
研究设计与样本
- 先导研究,纳入29例脑转移患者,年龄≥18岁,接受立体定向放疗(33 Gy/3次),实体瘤,卡氏功能状态≥70,MMSE≥24,无卒中脑损伤史。
- 患者于2014年6月至2015年4月招募,在SRT前及SRT后1个月、6个月、1年进行FAB、IHTTT及QLQ-C30评估。
- 主要终点为半球间转移指数(IHTI),次要终点包括半球间转移时间(IHTT)、MMSE、FAB及生活质量。
主要发现
- IHTT基线为720 ± 27 ms,1个月为728 ± 20 ms,6个月为736 ± 36 ms,1年随访为799 ± 111 ms(p = 0.0010)。
- IHTI基线为13.1 ± 31.4,1个月为11.5 ± 24.3,6个月为50.6 ± 57.9,1年随访为91.0 ± 59.4(p < 0.0001)。
- MMSE随时间显著变化(p = 0.014),但FAB评分及生活质量评分均无显著变化。
- IHTI与无进展生存期强相关(p = 0.0091)。
临床怎么用
- 作者认为IHTTT可能是一种有价值的敏感认知测试,可纳入接受SRT的脑转移患者的评估中。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the computerized Inter Hemispheric Transfer Time Test (IHTTT), a cognitive test designed for the detection of information processing speed impairment in patients undergoing stereotactic radiation therapy for brain metastases. METHODS: Inclusion criteria: age ≥18 years, brain metastases treated by stereotactic radiotherapy (SRT) with dose schedule: 33 Gy in 3 fractions, solid tumour, ≥70 Karnofsky Performance Status, Mini-Mental State Evaluation (MMSE) ≥ 24, no history of stroke brain injury. Twenty-nine patients were recruited from June 2014 to April 2015. All recruited patients were administered Frontal Assessment Battery at Bedside (FAB), IHTTT and QLQ-C30 quality of life questionnaire before SRT, at one-month, six-month and one-year follow-up. The primary endpoint was Interhemispheric Transfer Index (IHTI). Secondary endpoints included Interhemispheric Transfer Time (IHTT), MMSE, FAB, and quality of life. RESULTS: A significant evolution of cognitive function over time was assessed by the IHTTT: IHTT = 720 ± 27 ms at baseline, 728 ± 20 at one month, 736 ± 36 at 6 months, 799 ± 111 at one-year follow-up (p = 0.0010); IHTI = 13.1 ± 31.4, 11.5 ± 24.3, 50.6 ± 57.9, 91.0 ± 59.4 (p < 0.0001). There was also a significant evolution over time for MMSE (p = 0.014) but neither for FAB score nor the quality of life scores. IHTI was strongly related to progression-free survival (p = 0.0091). CONCLUSION: Our results suggest that IHTTT is able to detect the evolution of cognitive function over time. IHTTT could be an interesting sensitive cognitive test to include in evaluation of patients with brain metastases irradiated by SRT.
引用
- Reygagne E, Du Boisgueheneuc F, Berger A, et al. Examining the Inter Hemispheric Transfer Time Test: A new computerized cognitive test to incorporate into therapeutic strategy for patients with brain metastases? A pilot study. Clin Transl Radiat Oncol. 2018. PMID: 30993219. doi:10.1016/j.ctro.2018.11.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。